Related Experiment Videos
Fetal macrosomia: etiologic factors.
1St. Luke's-Roosevelt Hospital Center, Department of Obstetrics and Gynecology, New York, New York 10019, USA.
Clinical Obstetrics and Gynecology
|June 23, 2000
Summary
Fetal growth results from genetics and nutrient availability, primarily glucose. Focus should be on identifying and preventing accelerated fetal overgrowth to avoid adverse perinatal outcomes.
Area of Science:
- Perinatal medicine
- Fetal development
- Maternal-fetal interface
Background:
- Fetal growth is a complex process influenced by genetic factors and nutrient supply.
- Limitations in substrate availability, including amino acids, fatty acids, and glucose, constrain fetal growth.
- Most large infants are constitutionally large and do not experience adverse outcomes.
Purpose of the Study:
- To differentiate between constitutional and pathologic fetal overgrowth.
- To highlight the importance of identifying fetuses with accelerated growth.
- To emphasize primary prevention strategies for abnormal fetal overgrowth.
Main Methods:
- Review of existing literature on fetal growth determinants.
- Analysis of factors contributing to substrate availability.
- Discussion of diagnostic and management approaches for fetal overgrowth.
Main Results:
- Fetal growth is a balance between genetic potential and environmental constraints.
- Accelerated fetal overgrowth represents a pathologic condition requiring intervention.
- Constitutional large fetal size generally does not lead to adverse perinatal outcomes.
Conclusions:
- Management efforts should target pathologically overgrown fetuses.
- Primary prevention through maternal and fetal management is crucial.
- Distinguishing between normal and abnormal fetal growth is key for optimal perinatal care.